US Stock MarketDetailed Quotes
BCAB BioAtla
- 1.570
- +0.180+12.95%
Close Nov 22 16:00 ET
- 1.640
- +0.070+4.46%
Post 20:01 ET
75.90MMarket Cap-923P/E (TTM)
1.900High1.370Low1.56MVolume1.370Open1.390Pre Close2.49MTurnover4.49%Turnover RatioLossP/E (Static)48.35MShares4.02052wk High3.31P/B54.66MFloat Cap1.14052wk Low--Dividend TTM34.82MShs Float76.630Historical High--Div YieldTTM38.13%Amplitude1.140Historical Low1.590Avg Price1Lot Size
About BioAtla Company
BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA.
Company Profile
SymbolBCAB
Company NameBioAtla
Listing DateDec 16, 2020
Issue Price18.00
Founded2007
CEODr. Jay M. Short,PhD
MarketNASDAQ
Employees65
Fiscal Year Ends12-31
Address11085 Torreyana Road
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-558-0708
Websitehttp://www.BioAtla.com
Company Executives
- Name
- Position
- Salary
- Dr. Jay M. Short,PhD
- Chairman of the Board and Chief Executive Officer
- 3.30M
- Richard A. Waldron
- Senior Vice President and Chief Financial Officer
- 1.24M
- Christian Vasquez
- Chief Accounting Officer, Controller and Corporate Secretary
- --
- Dr. Eric Sievers, M.D.
- Chief Medical Officer
- 1.32M
- Scott A. Smith
- Director
- 1.27M
- Sylvia McBrinn
- Independent Director
- 164.57K
- Edward Williams
- Independent Director
- 168.94K
- Dr. Lawrence J. Steinman, M.D.
- Independent Director
- 161.19K
- Dr. Mary Ann Gray,PhD
- Independent Director
- 180.44K
- Dr. Susan Moran, M.D.
- Independent Director
- 158.19K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
